Literature DB >> 2645219

Immunocytochemical and biochemical analysis of epidermal growth factor receptor expression in human breast cancer tissues: relationship to estrogen receptor and lymphatic invasion.

M Toi1, Y Hamada, T Nakamura, H Mukaida, S Suehiro, T Wada, T Toge, M Niimoto, T Hattori.   

Abstract

Expression of epidermal growth factor receptor (EGFR) and estrogen receptor (ER) was examined by an immunocytochemical assay (ICA) using serial cross-sections of human breast cancer tissues. Immunocytochemical results were compared with those obtained by biochemical competitive binding assay and with histological lymphatic invasion. EGFR was evaluated as positive in 17 (34.0%) out of 50 primary tumors by ICA. A significant inverse relationship of the proportion of stained cells between EGFR and ER was demonstrated. In more than one-half of the tumors that were positive for both EGFR and ER, these 2 receptors were inversely stained in relation to the distribution. In ER-negative cells, EGFR expression was more marked than in ER-positive cells. Biochemical data confirmed the immunocytochemical results, pointing to an inverse relationship between EGFR and ER content. EGFR status correlated well with the degree of lymphatic invasion but not with the number of lymph nodes with metastases.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2645219     DOI: 10.1002/ijc.2910430208

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  17 in total

1.  Expression of epidermal growth factor receptor in normal colorectal mucosa, adenoma, and carcinoma.

Authors:  K Koretz; P Schlag; P Möller
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

Review 2.  Aberrant function of the Ras signal transduction pathway in human breast cancer.

Authors:  G J Clark; C J Der
Journal:  Breast Cancer Res Treat       Date:  1995-07       Impact factor: 4.872

3.  Prognostic relevance of epidermal growth factor receptor (EGF-R) and c-neu/erbB2 expression in glioblastomas (GBMs).

Authors:  E M Hiesiger; R L Hayes; D M Pierz; G N Budzilovich
Journal:  J Neurooncol       Date:  1993-05       Impact factor: 4.130

4.  Effects of lymphocytes and fibroblasts on the growth of human mammary carcinoma cells studied in short-term primary cultures.

Authors:  H M Ogmundsdóttir; I Pétursdóttir; I Gudmundsdóttir; L Amundadóttir; L Rønnov-Jessen; O W Petersen
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-12       Impact factor: 2.416

5.  Epidermal growth factor receptor in breast cancer: correlation of quantitative immunocytochemical assays to prognostic factors.

Authors:  C Charpin; B Devictor; P Bonnier; L Andrac; M N Lavaut; C Allasia; L Piana
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

6.  Epidermal growth factor receptor immunohistochemistry in different histological types of infiltrating breast carcinoma.

Authors:  M Martinazzi; F Crivelli; C Zampatti; S Martinazzi
Journal:  J Clin Pathol       Date:  1993-11       Impact factor: 3.411

7.  Epidermal growth factor receptor in breast cancer: storage conditions affecting measurement, and relationship to steroid receptors.

Authors:  W R McLeay; D J Horsfall; R Seshadri; D A Morrison; G T Saccone
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

8.  Raf-1 protein expression in human breast cancer cells.

Authors:  L S Callans; H Naama; M Khandelwal; R Plotkin; L Jardines
Journal:  Ann Surg Oncol       Date:  1995-01       Impact factor: 5.344

9.  Role of epidermal growth factor receptor expression in primary breast cancer: results of a biochemical study and an immunocytochemical study.

Authors:  M Toi; T Tominaga; A Osaki; T Toge
Journal:  Breast Cancer Res Treat       Date:  1994-01       Impact factor: 4.872

Review 10.  Autocrine growth factors and solid tumor malignancy.

Authors:  J H Walsh; W E Karnes; F Cuttitta; A Walker
Journal:  West J Med       Date:  1991-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.